TRANSPLANT RECIPIENT (KIDNEY)
Clinical trials for TRANSPLANT RECIPIENT (KIDNEY) explained in plain language.
Never miss a new study
Get alerted when new TRANSPLANT RECIPIENT (KIDNEY) trials appear
Sign up with your email to follow new studies for TRANSPLANT RECIPIENT (KIDNEY), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Pioneering trial aims to free kidney patients from lifelong drugs
Disease control Recruiting nowThis early-stage study is testing a new combination treatment designed to help the body accept a donated kidney without needing lifelong anti-rejection drugs. The treatment involves a special bone marrow infusion from the kidney donor, along with medications and low-dose radiatio…
Matched conditions: TRANSPLANT RECIPIENT (KIDNEY)
Phase: EARLY_PHASE1 • Sponsor: Tatsuo Kawai, MD, PhD • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Gene-Guided dosing aims to improve kidney transplant success
Disease control Recruiting nowThis study is testing whether checking a patient's genes before a kidney transplant can help doctors prescribe the correct starting dose of a crucial anti-rejection drug called tacrolimus. It will compare this genetic-guided approach to the current standard of care to see if it g…
Matched conditions: TRANSPLANT RECIPIENT (KIDNEY)
Phase: PHASE4 • Sponsor: Instituto de Investigación Hospital Universitario La Paz • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC